Collectively, these results demonstrate that HDAC2-mediated delactylation at the K17 site of DHX15 promotes bladder cancer progression, at least in part, by modulating the alternative splicing and downregulating the mature RPL9 transcript. Here, HDAC2 is linked to urinary bladder cancer.